Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study...

Clinical Cancer Research 2011 / 02 Vol. 17; Iss. 4

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors

Diamond, J. R., Bastos, B. R., Hansen, R. J., Gustafson, D. L., Eckhardt, S. G., Kwak, E. L., Pandya, S. S., Fletcher, G. C., Pitts, T. M., Kulikowski, G. N., Morrow, M., Arnott, J., Bray, M. R., Sido
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-10-2144
Date:
February, 2011
File:
PDF, 775 KB
english, 2011
Conversion to is in progress
Conversion to is failed